Additionally, the outcomes of Transwell migration (Figure 2C) and invasion (Figure 2D) assays indicated a significant reduction in the metastatic potential of NB cells upon NUTM2A‐AS1 silencing. The gene discussed is NUTM2A; the disease is neuroblastoma.